https://orcid.org/0000-0002-5597-2195
Citations (117)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Caitlin Fawcett, Joseph. R. Tickle & Charlotte. H. Coles. (2024) Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows. mAbs 16:1.
Read now
Read now
David L. Niquille, Kyle M. Fitzgerald & Nimish Gera. (2024) Biparatopic antibodies: therapeutic applications and prospects. mAbs 16:1.
Read now
Read now
Jing Dai, Saeed Izadi, Jonathan Zarzar, Patrick Wu, Angela Oh & Paul J. Carter. (2024) Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG1 antibody. mAbs 16:1.
Read now
Read now
Annarosa Arcangeli, Jessica Iorio & Claudia Duranti. (2024) Targeting the hERG1 and β1 integrin complex for cancer treatment. Expert Opinion on Therapeutic Targets 28:3, pages 145-157.
Read now
Read now
Paul Arras, Han Byul Yoo, Lukas Pekar, Christian Schröter, Thomas Clarke, Simon Krah, Daniel Klewinghaus, Vanessa Siegmund, Andreas Evers & Stefan Zielonka. (2023) A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization. mAbs 15:1.
Read now
Read now
Thomas Müller, Carolin Tasser, Michael Tesar, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch & Kristina Ellwanger. (2023) Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method. mAbs 15:1.
Read now
Read now
Lauren E. Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, Fang Yi, Rupesh Nanjunda, Sheng-Jiun Wu, Tun Liu, Eilyn R. Lacy, Steven Jacobs, Natalia Kozlyuk, Brian Del Rosario, Bingyuan Wu, Patricia Aquino, Robert C. Davidson, Samantha Heyne, Nicholas Mazzanti, James Testa, Michael D. Diem, Elsa Gorre, Andrew Mahan, Hirsh Nanda, Harsha P. Gunawardena, Alexis Gervais, Anthony A. Armstrong, Alexey Teplyakov, Chichi Huang, Adam Zwolak, Partha Chowdhury, Wan Cheung Cheung & Jinquan Luo. (2023) “Stapling” scFv for multispecific biotherapeutics of superior properties. mAbs 15:1.
Read now
Read now
Catherine Y Liu, Cory L Ahonen, Michael E Brown, Ling Zhou, Martin Welin, Eric M Krauland, Robert Pejchal, Paul F Widboom & Michael B Battles. (2023) Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity. mAbs 15:1.
Read now
Read now
Lennart Kühl, Annelie K. Schäfer, Sebastian Kraft, Nadine Aschmoneit, Roland E. Kontermann & Oliver Seifert. (2023) eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15:1.
Read now
Read now
Xingchen Li, Peng Zhang, Hao Sun, Lijie Han, Zhongxing Jiang & Jifeng Yu. (2023) Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting. Expert Opinion on Biological Therapy 23:12, pages 1193-1195.
Read now
Read now
Thomas Sécher & Nathalie Heuzé-Vourc’h. (2023) Barriers for orally inhaled therapeutic antibodies. Expert Opinion on Drug Delivery 20:8, pages 1071-1084.
Read now
Read now
Articles from other publishers (106)
Mirko Minervini, Ali Behboudi, Jovana R. Marzella & Andrew L. Zydney. (2024) Optimizing particle morphology during antibody precipitation for enhanced tangential flow filtration performance. Separation and Purification Technology 338, pages 126574.
Crossref
Crossref
Xingguo Hou, Song Liu, Ziqing Zeng, Zilei Wang, Jin Ding, Yan Chen, Xiangyu Gao, Jianghua Wang, Guanxi Xiao, Baiyong Li, Hua Zhu & Zhi Yang. (2024) Preclinical imaging evaluation of a bispecific antibody targeting hPD1/CTLA4 using humanized mice. Biomedicine & Pharmacotherapy 175, pages 116669.
Crossref
Crossref
Cui Li, Qing-qing Yao & Jiang Li. (2024) Druggability properties of a L309K mutation in the antibody CH2 domain. 3 Biotech 14:6.
Crossref
Crossref
Risa Asano, Miyu Takeuchi, Makoto Nakakido, Sho Ito, Chihiro Aikawa, Takeshi Yokoyama, Akinobu Senoo, Go Ueno, Satoru Nagatoishi, Yoshikazu Tanaka, Ichiro Nakagawa & Kouhei Tsumoto. (2024)
Characterization of a novel format
scFv
×
VHH
single‐chain biparatopic antibody against metal binding protein
MtsA
. Protein Science 33:6.
Crossref
Crossref
Chee-Hing Yang, Hui-Chun Li & Shih-Yen Lo. (2024) Enhancing recombinant antibody yield in Chinese hamster ovary cells. Tzu Chi Medical Journal.
Crossref
Crossref
Camille Rolin, Jacques Zimmer & Carole Seguin-Devaux. (2024) Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases. Cellular & Molecular Immunology.
Crossref
Crossref
María Iglesias-Caballero, Vicente Mas, Sonia Vázquez-Morón, Mónica Vázquez, Sara Camarero-Serrano, Olga Cano, Concepción Palomo, María José Ruano, Cristina Cano-Gómez, José Antonio Infantes-Lorenzo, Albert Campoy, Montserrat Agüero, Francisco Pozo & Inmaculada Casas. (2024) Genomic Context of SARS-CoV-2 Outbreaks in Farmed Mink in Spain during Pandemic: Unveiling Host Adaptation Mechanisms. International Journal of Molecular Sciences 25:10, pages 5499.
Crossref
Crossref
Toby Journeaux & Gonçalo J. L. Bernardes. (2024) Homogeneous multi-payload antibody–drug conjugates. Nature Chemistry.
Crossref
Crossref
Adrián Sanvicente García, Manuel Pedregal, Lucía Paniagua-Herranz, Cristina Díaz-Tejeiro, Cristina Nieto-Jiménez, Pedro Pérez Segura, Gyöngyi Munkácsy, Balázs Győrffy, Emiliano Calvo, Víctor Moreno & Alberto Ocaña. (2024) Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D. International Journal of Molecular Sciences 25:10, pages 5345.
Crossref
Crossref
Ines Zimmermann, Yasmin Kaveh-Baghbaderani, Friederike Eilts, Nadja Kohn, Paula Fraga-García & Sonja Berensmeier. (2024) Direct Affinity Ligand Immobilization onto Bare Iron Oxide Nanoparticles Enables Efficient Magnetic Separation of Antibodies. ACS Applied Bio Materials.
Crossref
Crossref
Rania Benazza, Ilias Koutsopetras, Valentine Vaur, Guilhem Chaubet, Oscar Hernandez-Alba & Sarah Cianférani. (2024) SEC-MS in denaturing conditions (dSEC-MS) for in-depth analysis of rebridged monoclonal antibody-based formats. Talanta 272, pages 125727.
Crossref
Crossref
Prabir Kumar Das, Ansuman Sahoo & Venkata Dasu Veeranki. (2024) Recombinant monoclonal antibody production in yeasts: Challenges and considerations. International Journal of Biological Macromolecules 266, pages 131379.
Crossref
Crossref
Gizem Kayki-Mutlu, Zinnet Sevval Aksoyalp, Leszek Wojnowski & Martin C. Michel. (2024) A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023. Naunyn-Schmiedeberg's Archives of Pharmacology 397:5, pages 2949-2970.
Crossref
Crossref
Arman Izadi, Yasaman Karami, Eleni Bratanis, Sebastian Wrighton, Hamed Khakzad, Maria Nyblom, Berit Olofsson, Lotta Happonen, Di Tang, Martin Sundwall, Magdalena Godzwon, Yashuan Chao, Alejandro Gomez Toledo, Tobias Schmidt, Mats Ohlin, Michael Nilges, Johan Malmström, Wael Bahnan, Oonagh Shannon, Lars Malmström & Pontus Nordenfelt. (2024) The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies. Nature Communications 15:1.
Crossref
Crossref
Amita Datta-Mannan, Hiuwan Choi, Zhaoyan Jin, Ling Liu, Jirong Lu, David J. Stokell, Anthony T. Murphy, Kenneth W. Dunn, Michelle M. Martinez & Yiqing Feng. (2024) Reducing target binding affinity improves the therapeutic index of anti-MET antibody-drug conjugate in tumor bearing animals. PLOS ONE 19:4, pages e0293703.
Crossref
Crossref
Sandeep, Suraj H. Shinde, Sakeel Ahmed, Shyam Sunder Sharma & Abhay H. Pande. (2023) Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics. Immunology 171:4, pages 464-496.
Crossref
Crossref
Silje Skrede, Nataša Bogavac‐Stanojević, Erwin Dreesen, Elisabet Nielsen, Martina Zaninotto & Denis Mulleman. (2024) Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe. Basic & Clinical Pharmacology & Toxicology 134:4, pages 556-560.
Crossref
Crossref
Hanna Beyer, Mark Sommerfeld, Kaj Grandien, Christine Faust, Bodo Tillmann, Wulf Dirk Leuschner, Anne Régnier‐Vigouroux, Sandra Weil, Ercole Rao & Thomas Langer. (2024)
Functional studies with
IgM
and
IgA
immunoglobulins: binding to
pIgR
,
FcαμR
,
FcμR,
and
CDC
activities
. APMIS 132:4, pages 277-288.
Crossref
Crossref
Monika Prašnikar, Matic Proj, Maja Bjelošević Žiberna, Blaž Lebar, Benjamin Knez, Nika Kržišnik, Robert Roškar, Stanislav Gobec, Iztok Grabnar, Aleš Žula & Pegi Ahlin Grabnar. (2024) The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions. International Journal of Pharmaceutics 655, pages 124055.
Crossref
Crossref
Francesca Matilde Schipilliti, Denise Drittone, Federica Mazzuca, Daniele La Forgia, Deniz Can Guven & Alessandro Rizzo. (2024) Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer. Heliyon 10:7, pages e28385.
Crossref
Crossref
Fernando Santos‐Beneit. (2024) What is the role of microbial biotechnology and genetic engineering in medicine?. MicrobiologyOpen 13:2.
Crossref
Crossref
Lena Gaugler, Sebastian Hofmann, Michael Schlüter & Ralf Takors. (2024) Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior. Biotechnology and Bioengineering 121:4, pages 1243-1255.
Crossref
Crossref
Zhe Ma, Zhenxing Zhou, Wenwen Duan, Gaofeng Yao, Shimei Sheng, Sidou Zong, Xin Zhang, Changkui Li, Yuanyuan Liu, Fengting Ou, Maha Raja Dahar, Yanshan Huang & Lushan Yu. (2024) DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy. Cancer Immunology, Immunotherapy 73:5.
Crossref
Crossref
William R Strohl. (2024) Structure and function of therapeutic antibodies approved by the US FDA in 2023. Antibody Therapeutics 7:2, pages 132-156.
Crossref
Crossref
Arthur Giraud, Lionel Imbert, Adrien Favier, Faustine Henot, Francis Duffieux, Camille Samson, Oriane Frances, Elodie Crublet & Jérôme Boisbouvier. (2024) Enabling site-specific NMR investigations of therapeutic Fab using a cell-free based isotopic labeling approach: application to anti-LAMP1 Fab. Journal of Biomolecular NMR.
Crossref
Crossref
Mikhail Kuravsky, Glyn F. Gibbons, Callum Joyce, Anthony Scott-Tucker, Alex Macpherson & Alastair D. G. Lawson. (2024) Modular design of bi- and multi-specific knob domain fusions. Frontiers in Immunology 15.
Crossref
Crossref
Rika Tandiana, German P. Barletta, Miguel Angel Soler, Sara Fortuna & Walter Rocchia. (2024)
Computational Mutagenesis of Antibody Fragments: Disentangling Side Chains from ΔΔ
G
Predictions
. Journal of Chemical Theory and Computation 20:6, pages 2630-2642.
Crossref
Crossref
Anna-Lena M. Fischer, Anna Tichy, Janik Kokot, Valentin J. Hoerschinger, Robert F. Wild, Jakob R. Riccabona, Johannes R. Loeffler, Franz Waibl, Patrick K. Quoika, Philipp Gschwandtner, Stefano Forli, Andrew B. Ward, Klaus R. Liedl, Martin Zacharias & Monica L. Fernández-Quintero. (2024) The Role of Force Fields and Water Models in Protein Folding and Unfolding Dynamics. Journal of Chemical Theory and Computation 20:5, pages 2321-2333.
Crossref
Crossref
Stian Foss, Siri A. Sakya, Leire Aguinagalde, Marta Lustig, Jutamas Shaughnessy, Ana Rita Cruz, Lisette Scheepmaker, Line Mathiesen, Fulgencio Ruso-Julve, Aina Karen Anthi, Torleif Tollefsrud Gjølberg, Simone Mester, Malin Bern, Mitchell Evers, Diane B. Bratlie, Terje E. Michaelsen, Tilman Schlothauer, Devin Sok, Jayanta Bhattacharya, Jeanette Leusen, Thomas Valerius, Sanjay Ram, Suzan H. M. Rooijakkers, Inger Sandlie & Jan Terje Andersen. (2024) Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nature Communications 15:1.
Crossref
Crossref
Ellena Nador, Chaoshuang Xia, Philip J. Santangelo, Kevin J. Whaley, Catherine E. Costello & Deborah J. Anderson. (2024) Platform-Specific Fc N-Glycan Profiles of an Antisperm Antibody. Antibodies 13:1, pages 17.
Crossref
Crossref
Ling Zhou, Yunlong Lu, Wei Liu, Shanglong Wang, Lingling Wang, Pengdou Zheng, Guisha Zi, Huiguo Liu, Wukun Liu & Shuang Wei. (2024) Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice. Experimental Hematology & Oncology 13:1.
Crossref
Crossref
Yuka Tanaka, Takamichi Ito, Maho Murata, Keiko Tanegashima, Yumiko Kaku‐Ito & Takeshi Nakahara. (2024) NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease. Experimental Dermatology 33:3.
Crossref
Crossref
Maximilian Wozniewski, Ahmed Besheer, Jörg Huwyler, Hanns-Christian Mahler, Vincent Levet & Ahmad S. Sediq. (2024) A Survey on Handling and Administration of Therapeutic Protein Products in German and Swiss Hospitals. Journal of Pharmaceutical Sciences 113:3, pages 735-743.
Crossref
Crossref
Thomas Bouvarel, Julien Camperi & Davy Guillarme. (2024) Multi‐dimensional technology – Recent advances and applications for biotherapeutic characterization. Journal of Separation Science 47:5.
Crossref
Crossref
Jieru Chen, Xiaoxuan Lin, Fang Sun, Huilin Wen, Zhenxiang Huang, Wenying Li, Le Jiang, Ziyi Yu & Chi Hu. (2024) Single Cell Microgels for High‐Throughput Magnetic Sorting and Sequencing of Antigen‐Specific Antibodies. Advanced Functional Materials.
Crossref
Crossref
Philipp Mohr, Joyce van Sluis, Marjolijn N. Lub-de Hooge, Adriaan A. Lammertsma, Adrienne H. Brouwers & Charalampos Tsoumpas. (2024) Advances and challenges in immunoPET methodology. Frontiers in Nuclear Medicine 4.
Crossref
Crossref
Benqian Wei, Carter Lantz, Rachel R. Ogorzalek Loo, Iain D. G. Campuzano & Joseph A. Loo. (2024) Internal Fragments Enhance Middle-Down Mass Spectrometry Structural Characterization of Monoclonal Antibodies and Antibody-Drug Conjugates. Analytical Chemistry 96:6, pages 2491-2499.
Crossref
Crossref
Traian Sulea, Sandeep Kumar & Daisuke Kuroda. (2024) Editorial: Progress and challenges in computational structure-based design and development of biologic drugs. Frontiers in Molecular Biosciences 11.
Crossref
Crossref
Arpon BiswasAbhijit Deb ChoudhurySristi AgrawalAmol Chhatrapati BisenSachin Nashik SanapSarvesh Kumar VermaMukesh KumarAnjali MishraShivansh KumarMridula ChauhanRabi Sankar Bhatta. (2024) Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management. Journal of Ocular Pharmacology and Therapeutics 40:1, pages 13-33.
Crossref
Crossref
Wen-Bin Zhao, Ying Shen, Guo-Xin Cai, Yi-Ming Li, Wen-Hui Liu, Jing-Cheng Wu, Ying-Chun Xu, Shu-Qing Chen & Zhan Zhou. (2024) Superantigen-fused T cell engagers for tumor antigen-mediated robust T cell activation and tumor cell killing. Molecular Therapy 32:2, pages 490-502.
Crossref
Crossref
Krishnan Sampathkumar & Bruce A. Kerwin. (2024) Roadmap for Drug Product Development and Manufacturing of Biologics. Journal of Pharmaceutical Sciences 113:2, pages 314-331.
Crossref
Crossref
Tessa Reinert, Pascal Houzé, Yannis-Nicolas Francois & Rabah Gahoual. (2024) Enhancing affinity purification of monoclonal antibodies from human serum for subsequent CZE-MS analysis. Journal of Chromatography B 1234, pages 123974.
Crossref
Crossref
Marika E. Reinau & Dennis Åsberg. (2024) Characterization of antibody surface properties and selection of a diverse subset for development of a generic size-exclusion chromatography method. Journal of Chromatography A 1716, pages 464652.
Crossref
Crossref
Saeko Yanaka, Hiroki Watanabe, Rina Yogo, Mesayamas Kongsema, Sachiko Kondo, Hirokazu Yagi, Takayuki Uchihashi & Koichi Kato. (2024) Quantitative Analysis of Therapeutic Antibody Interactions with Fcγ Receptors Using High-Speed Atomic Force Microscopy. Biological and Pharmaceutical Bulletin 47:1, pages 334-338.
Crossref
Crossref
Mikhail N. Tereshin, Tatiana D. Melikhova, Barbara Z. Eletskaya, Olga B. Ksenofontova, Pavel V. Pantyushenko, Maria Ya. Berzina, Igor Ivanov, Igor V. Myagkikh & Vasiliy N. Stepanenko. (2024) Affinity Resins for the Isolation of Immunoglobulins G Obtained Using Biocatalytic Technology. International Journal of Molecular Sciences 25:3, pages 1367.
Crossref
Crossref
Aubin Ramon, Montader Ali, Misha Atkinson, Alessio Saturnino, Kieran Didi, Cristina Visentin, Stefano Ricagno, Xing Xu, Matthew Greenig & Pietro Sormanni. (2024) Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV. Nature Machine Intelligence 6:1, pages 74-91.
Crossref
Crossref
Jingjing Su, Yiting Fu, Zitong Cui, Zain Abidin, Jingsong Yuan, Xinmiao Zhang, Runmin Li & Chunzhen Zhao. (2024) Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy. Frontiers in Pharmacology 14.
Crossref
Crossref
Theresa A. Gozzo & Matthew F. Bush. (2023) Quantitatively Differentiating Antibodies Using Charge-State Manipulation, Collisional Activation, and Ion Mobility-Mass Spectrometry. Analytical Chemistry 96:1, pages 505-513.
Crossref
Crossref
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, Janine Schuurman, Aran F. Labrijn, Theo Rispens & Gestur Vidarsson. (2024) Impact of structural modifications of IgG antibodies on effector functions. Frontiers in Immunology 14.
Crossref
Crossref
Brennan Abanades, Tobias H Olsen, Matthew I J Raybould, Broncio Aguilar-Sanjuan, Wing Ki Wong, Guy Georges, Alexander Bujotzek & Charlotte M Deane. (2024) The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures. Nucleic Acids Research 52:D1, pages D545-D551.
Crossref
Crossref
Pankaj Gupta, Alexander M. Horspool, Goral Trivedi, Gina Moretti, Akshita Datar, Zhong-Fu Huang, Jeffrey Chiecko, Cynthia Hess Kenny & Michael S. Marlow. (2024) Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability. Journal of Biological Chemistry 300:1, pages 105555.
Crossref
Crossref
Suraj H. Shinde, Sandeep & Abhay H. Pande. (2024) Polyvalency: an emerging trend in the development of clinical antibodies. Drug Discovery Today 29:1, pages 103846.
Crossref
Crossref
Sagar, Malemnganba Takhellambam, Aditi Rattan & Vijay Kumar Prajapati. 2024. Immunology for Engineers. Immunology for Engineers
1
36
.
Guofeng Zhao, Yongbo Li, Yuntao Wu, Shanshan Li, Xiaomei Chen, Wei Zhang & Jin Xie. 2024. Ion-Exchange Chromatography and Related Techniques. Ion-Exchange Chromatography and Related Techniques
505
520
.
Corentin Beaumal, Evolène Deslignière, Hélène Diemer, Christine Carapito, Sarah Cianférani & Oscar Hernandez-Alba. (2023) Improved characterization of trastuzumab deruxtecan with PTCR and internal fragments implemented in middle-down MS workflows. Analytical and Bioanalytical Chemistry 416:2, pages 519-532.
Crossref
Crossref
Thomas Wölfel. 2024.
Anthony Cheung & Alicia Chenoweth. (2023) Targeted Immunotherapies for Cancers. Cancers 16:1, pages 11.
Crossref
Crossref
Marisa Delgado & Jose A. Garcia-Sanz. (2023) Therapeutic Monoclonal Antibodies against Cancer: Present and Future. Cells 12:24, pages 2837.
Crossref
Crossref
Lin Sun, Somanath Kallolimath, Roman Palt, Florian Eminger, Richard Strasser & Herta Steinkellner. (2023) Codon optimization regulates IgG3 and IgM expression and glycosylation in N. benthamiana. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Jie Li, Yang Yang, Zhongyi Fan, Zhiqiang Huang, Jun Chen & Qing Liu. (2023) Salmonella typhimurium targeting with monoclonal antibodies prevents infection in mice. PLOS Neglected Tropical Diseases 17:12, pages e0011579.
Crossref
Crossref
Evgeny L. Gulyak, Vera A. Alferova, Vladimir A. Korshun & Ksenia A. Sapozhnikova. (2023) Introduction of Carbonyl Groups into Antibodies. Molecules 28:23, pages 7890.
Crossref
Crossref
Xiaohan Guo, Yi Wu, Ying Xue, Na Xie & Guobo Shen. (2023) Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment. Frontiers in Immunology 14.
Crossref
Crossref
Patanachai K. Limpikirati, Sorrayut Mongkoltipparat, Thinnaphat Denchaipradit, Nathathai Siwasophonpong, Wudthipong Pornnopparat, Parawan Ramanandana, Phumrapee Pianpakt, Songsak Tongchusak, Maoxin Tim Tian & Trairak Pisitkun. (2023) Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics. Journal of Pharmaceutical Analysis.
Crossref
Crossref
Matthew Billups, Mirko Minervini, Melissa Holstein, Hasin Feroz, Swarnim Ranjan, Jessica Hung & Andrew L. Zydney. (2023) The role of intermolecular interactions on monoclonal antibody filtration through virus removal membranes. Biotechnology Journal 18:12.
Crossref
Crossref
Donald Gagné, Muzaddid Sarker, Geneviève Gingras, Derek J. Hodgson, Grant Frahm, Marybeth Creskey, Barry Lorbetskie, Stewart Bigelow, Jun Wang, Xu Zhang, Michael J. W. Johnston, Huixin Lu & Yves Aubin. (2023) Strategies for the production of isotopically labelled Fab fragments of therapeutic antibodies in Komagataella phaffii (Pichia pastoris) and Escherichia coli for NMR studies. PLOS ONE 18:11, pages e0294406.
Crossref
Crossref
Rachel Liuqing Shi, Michael A. Dillon, Philip D. Compton, William S. Sawyer, John R. Thorup, Mandy Kwong, Pamela Chan, Cecilia P. C. Chiu, Ran Li, Rajbharan Yadav, Genee Y. Lee, Joshua G. Gober, Zhiyu Li, Adel M. ElSohly, Ayse Meric Ovacik, James T. Koerber, Christoph Spiess, Jonathan L. Josephs & John C. Tran. (2023) High-Throughput Analyses of Therapeutic Antibodies Using High-Field Asymmetric Waveform Ion Mobility Spectrometry Combined with SampleStream and Intact Protein Mass Spectrometry. Analytical Chemistry 95:47, pages 17263-17272.
Crossref
Crossref
Jérôme Castel, Sarah Delaux, Oscar Hernandez-Alba & Sarah Cianférani. (2023) Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures. Journal of Pharmaceutical and Biomedical Analysis 236, pages 115696.
Crossref
Crossref
Chenyang Yu, Yingzhao Huang, Wei Yan & Xian Jiang. (2023) A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis. Frontiers in Immunology 14.
Crossref
Crossref
Monica L. Fernández-Quintero, Nancy D. Pomarici, Anna-Lena M. Fischer, Valentin J. Hoerschinger, Katharina B. Kroell, Jakob R. Riccabona, Anna S. Kamenik, Johannes R. Loeffler, James A. Ferguson, Hailee R. Perrett, Klaus R. Liedl, Julianna Han & Andrew B. Ward. (2023) Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines. Antibodies 12:4, pages 67.
Crossref
Crossref
Xiaoqing Jin & Bingfang He. (2023) Combination of On-Line and Off-Line Two-Dimensional Liquid Chromatography-Mass Spectrometry for Comprehensive Characterization of mAb Charge Variants and Precise Instructions for Rapid Process Development. International Journal of Molecular Sciences 24:20, pages 15184.
Crossref
Crossref
Aleksandra Rodak, Katharina Stadlbauer, Madhusudhan Reddy Bobbili, Oskar Smrzka, Florian Rüker & Gordana Wozniak Knopp. (2023) Development of a Cytotoxic Antibody–Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells. International Journal of Molecular Sciences 24:19, pages 14997.
Crossref
Crossref
Kuin Tian Pang, Yuan Sheng Yang, Wei Zhang, Ying Swan Ho, Pietro Sormanni, Thomas C.T. Michaels, Ian Walsh & Sean Chia. (2023) Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics. Biotechnology Advances 67, pages 108192.
Crossref
Crossref
Yong Hwan Choi, Ha Seung Song, Su Keun Lee, Chi Hun Song, Ji Hoe Kim & Kyung Ho Han. (2023) Advancements in Bispecific Antibody Development and Research Trends. Microbiology and Biotechnology Letters 51:3, pages 223-242.
Crossref
Crossref
Dalia T. Abdeldaim & Katharina Schindowski. (2023) Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions. Pharmaceutics 15:10, pages 2402.
Crossref
Crossref
Jorge Roel-Touris, Marta Nadal & Enrique Marcos. (2023) Single-chain dimers from de novo immunoglobulins as robust scaffolds for multiple binding loops. Nature Communications 14:1.
Crossref
Crossref
Federico Riccardi, Michele Dal Bo, Paolo Macor & Giuseppe Toffoli. (2023) A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy. Frontiers in Pharmacology 14.
Crossref
Crossref
Xiaofeng Jiang, Ling Sun, Chengwu Hu, Feijian Zheng, Zhengbing Lyu & Jianzhong Shao. (2023) Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?. Marine Drugs 21:9, pages 496.
Crossref
Crossref
Matthew D Smith, Marshall A Case, Emily K Makowski & Peter M Tessier. (2023) Position-Specific Enrichment Ratio Matrix scores predict antibody variant properties from deep sequencing data. Bioinformatics 39:9.
Crossref
Crossref
Atsushi Kuwahara, Kazunori Ikebukuro & Ryutaro Asano. (2023) Protein engineering of antibody fragments for pharmaceutical production. Applied Physics Reviews 10:3.
Crossref
Crossref
Emmanuel Douez, Valentina D’Atri, Davy Guillarme, Daniel Antier, Mathieu Guerriaud, Alain Beck, Hervé Watier & Laura Foucault-Fruchard. (2023) Why is there no biosimilar of Erbitux®?. Journal of Pharmaceutical and Biomedical Analysis 234, pages 115544.
Crossref
Crossref
Tessa Reinert, Pascal Houzé, Nathalie Mignet, Yannis-Nicolas Francois & Rabah Gahoual. (2023) Post-translational modifications comparative identification and kinetic study of infliximab innovator and biosimilars in serum using capillary electrophoresis-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 234, pages 115541.
Crossref
Crossref
Junxiang Zhou, Han Deng & Hongtao Xiao. (2023) Research and development of antibody-based novel anti-cancer drugs: An overview. Intelligent Pharmacy 1:2, pages 90-95.
Crossref
Crossref
Yan-Na Sun, Wu-Wei Chen, Shan-Jing Yao & Dong-Qiang Lin. (2023) Model-assisted process development, characterization and design of continuous chromatography for antibody separation. Journal of Chromatography A 1707, pages 464302.
Crossref
Crossref
Szabolcs Fekete & Davy Guillarme. (2023) Ultra-short columns for the chromatographic analysis of large molecules. Journal of Chromatography A 1706, pages 464285.
Crossref
Crossref
Wonju Lee, Sang Min Lee & Sang Taek Jung. (2023) Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments. BioDrugs 37:5, pages 637-648.
Crossref
Crossref
Francis Gaudreault, Jason Baardsnes, Yuliya Martynova, Aurore Dachon, Hervé Hogues, Christopher R. Corbeil, Enrico O. Purisima, Mélanie Arbour & Traian Sulea. (2023) Exploring rigid-backbone protein docking in biologics discovery: a test using the DARPin scaffold. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Kim Dua Nguyen, Hiroyuki Kajiura, Ryo Kamiya, Takahiro Yoshida, Ryo Misaki & Kazuhito Fujiyama. (2023) Production and N-glycan engineering of Varlilumab in Nicotiana benthamiana. Frontiers in Plant Science 14.
Crossref
Crossref
Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert & Alain Beck. (2023) Antibody–drug conjugates come of age in oncology. Nature Reviews Drug Discovery 22:8, pages 641-661.
Crossref
Crossref
Miusi Shi & Kevin J. McHugh. (2023) Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems. Advanced Drug Delivery Reviews 199, pages 114904.
Crossref
Crossref
Corentin Beaumal, Alain Beck, Oscar Hernandez‐Alba & Christine Carapito. (2023) Advanced mass spectrometry workflows for accurate quantification of trace‐level host cell proteins in drug products: Benefits of FAIMS separation and gas‐phase fractionation DIA. PROTEOMICS 23:16.
Crossref
Crossref
Tereza Husarova, William M. MacCuaig, Isabel S. Dennahy, Emma J. Sanderson, Barish H. Edil, Ajay Jain, Morgan M. Bonds, Molly W. McNally, Katerina Menclova, Jiri Pudil, Pavel Zaruba, Radek Pohnan, Christina E. Henson, William E. Grizzle & Lacey R. McNally. (2023) Intraoperative Imaging in Hepatopancreatobiliary Surgery. Cancers 15:14, pages 3694.
Crossref
Crossref
J. Paul Robinson, Raluca Ostafe, Sharath Narayana Iyengar, Bartek Rajwa & Rainer Fischer. (2023) Flow Cytometry: The Next Revolution. Cells 12:14, pages 1875.
Crossref
Crossref
Reyad Dada. (2023) Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel Antibodies Take on CART and BMT in the Quest for Future Treatment Strategies. Cells 12:14, pages 1858.
Crossref
Crossref
Igor Jaszczyszyn, Weronika Bielska, Tomasz Gawlowski, Pawel Dudzic, Tadeusz Satława, Jarosław Kończak, Wiktoria Wilman, Bartosz Janusz, Sonia Wróbel, Dawid Chomicz, Jacob D. Galson, Jinwoo Leem, Sebastian Kelm & Konrad Krawczyk. (2023) Structural modeling of antibody variable regions using deep learning—progress and perspectives on drug discovery. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Lucía Paniagua-Herranz, Bernard Doger, Cristina Díaz-Tejeiro, Adrián Sanvicente, Cristina Nieto-Jiménez, Víctor Moreno, Pedro Pérez Segura, Balazs Gyorffy, Emiliano Calvo & Alberto Ocana. (2023) Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities. Cancers 15:12, pages 3250.
Crossref
Crossref
Ahlam N. QerqezRui P. Silva & Jennifer A. Maynard. (2023) Outsmarting Pathogens with Antibody Engineering. Annual Review of Chemical and Biomolecular Engineering 14:1, pages 217-241.
Crossref
Crossref
Somar Khalil, Nisha Patel, Francoise Bevillard-Kumar, Cyrille Chéry, William Burkitt, John O’Hara & Annick Gervais. (2023) Characterization and validation of a middle-down hydrophobic interaction chromatography method to monitor methionine oxidation in IgG1. Journal of Pharmaceutical and Biomedical Analysis Open 1, pages 100008.
Crossref
Crossref
Evi B. Struble, Jonathan M. O. Rawson, Tzanko Stantchev, Dorothy Scott & Marjorie A. Shapiro. (2023) Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies. Pharmaceutics 15:5, pages 1538.
Crossref
Crossref
Getu Zhaori. (2023) Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design. Pediatric Investigation.
Crossref
Crossref
Yair Kaufman, KC Hunt, Gabriel Hale, Matthew McClure, David Latulippe, Madhavi Sivan, Jack Wilson, Rachel Dorin, Yury Agroskin, Marty Siwak & Daniele Gerion. (2023) Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content. Biotechnology and Bioengineering.
Crossref
Crossref
Aude I. Segaliny, Jayapriya Jayaraman, Xiaoming Chen, Jonathan Chong, Ryan Luxon, Audrey Fung, Qiwei Fu, Xianzhi Jiang, Rodrigo Rivera, Xiaoya Ma, Ci Ren, Jan Zimak, Per Niklas Hedde, Yonglei Shang, George Wu & Weian Zhao. (2023) A high throughput bispecific antibody discovery pipeline. Communications Biology 6:1.
Crossref
Crossref
Bing Sun, Ningshao Xia & Xuan Zhang. (2023) Progress in immunotherapy. Science China Life Sciences 66:4, pages 653-657.
Crossref
Crossref
Emilie Mausser, Ellena Nador, Joseph A. Politch, Michael R. Pauly, Jai G. Marathe, Thomas R. Moench, Larry Zeitlin, Kevin J. Whaley & Deborah J. Anderson. (2023) LALAPG variant of the Human Contraception Antibody (HCA) reduces Fc-mediated effector functions while maintaining sperm agglutination activity. PLOS ONE 18:3, pages e0282147.
Crossref
Crossref
Thomas Bouvarel, Nadine Bremeyer, Mimi Gao, Wiebke Holkenjans, Terence Hetzel, Reinhard Pell, Valentina D’Atri & Davy Guillarme. (2023) Tackling Issues Observed during the Development of a Liquid Chromatography Method for Small Molecule Quantification in Antibody-Chelator Conjugate. Molecules 28:6, pages 2626.
Crossref
Crossref
Suthimon Thumtecho, Nick J. Burlet, Anne Ljungars & Andreas H. Laustsen. (2023) Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies. Journal of Venomous Animals and Toxins including Tropical Diseases 29.
Crossref
Crossref
Wenbin Zhao, Xiaowei Luo, Fan Tong, Xiangwen Zheng, Jing Li, Guangyu Zhao & Dongsheng Zhao. (2023) Improving antibody optimization ability of generative adversarial network through large language model. Computational and Structural Biotechnology Journal 21, pages 5839-5850.
Crossref
Crossref